Combi-seq versus traditional approaches for testing drug combinations. (IMAGE)
Caption
Due to the limited amount of patient tissue, only a few drug combinations can be tested in the traditional approach. The results of testing are binary in nature, i.e. whether the tumour cells live or die upon treatment, so we can only answer the question 'Is the patient resistant or responsive to this drug combination?'
Credit
Aleksandra Krolik/EMBL
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. Adaptations must be shared under the same terms.
License
CC BY-NC-SA